$0.00
(0.00%
) Quote details
USD
$0.00
(0.00%
)At Close (As of Oct 31, 2025)
$900.63M
Market Cap
-
P/E Ratio
-0.14
EPS
$17.07
52 Week High
$7.31
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Pharming Group NV is a leading specialty pharmaceutical company based in Leiden, the Netherlands, committed to developing innovative therapies for rare diseases and unmet medical needs worldwide. Utilizing its proprietary recombinant DNA technology, Pharming produces safe and effective treatments with a significant focus on improving patient outcomes. The company's strong presence in the United States and Europe underscores its dedication to addressing critical health challenges, providing access to life-saving therapies, and advancing the biopharmaceutical industry. Through its robust pipeline and strategic partnerships, Pharming continues to position itself as a key player in the market for rare disease treatments.
EPWK
VHAI
HKD
MSAI
NVDA
BENF
PFE
ASST
DVLT
BYND
PLUG
NOK
MSPR
T
DNN
QS
TSLA
INTC
BITF
RIG
F
NWL
RGTI
SOFI
ADTX
LAZR
META
PLTR
VZ
CAN
NIO
ADAP
CMG
LUMN
WULF
KVUE
VALE
SNAP
CCL
AAL
CIFR
WBD
JOBY
RXRX
GRAB
TLRY
BAC
GOOGL
AMCR
QBTS
CABA
AMD
MSFT
LAES
HPE
MARA
RIOT
KDLY
BTBT
APLD
KHC
FI
GOOG
MRVL
SOUN
FUBO
NVTS
DXCM
EPWK
VHAI
HKD
MSAI
NVDA
BENF
PFE
ASST
DVLT
BYND
PLUG
NOK
MSPR
T
DNN
QS
TSLA
INTC
BITF
RIG
F
NWL
RGTI
SOFI
ADTX
LAZR
META
PLTR
VZ
CAN
NIO
ADAP
CMG
LUMN
WULF
KVUE
VALE
SNAP
CCL
AAL
CIFR
WBD
JOBY
RXRX
GRAB
TLRY
BAC
GOOGL
AMCR
QBTS
CABA
AMD
MSFT
LAES
HPE
MARA
RIOT
KDLY
BTBT
APLD
KHC
FI
GOOG
MRVL
SOUN
FUBO
NVTS
DXCM